Bladder Cancer: Our Clinical Trials

Title	Investigator
A Genotype-Phenotype Urothelial Cancer Study [Protocol 09-025]	Bajorin, Dean, MD
A Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy [Protocol 10-031]	Kollmeier, Marisa, MD
A Phase I Trial of Gemcitabine and Split-Dose Cisplatin plus Everolimus in Patients with Advanced Urothelial Cancer [Protocol 10-106]	Bajorin, Dean, MD
A Phase I/II Study of CDX-1401 in Patients with Cancers Known to Express NY-ESO-1 [Protocol 09-165]	Keohan, Mary, MD
A Phase I/II Study of Everolimus and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Non-Muscle-Invasive Bladder Cancer [Protocol 10-165]	Dalbagni, Guido, MD
A Phase II Study of DN24-02 as Adjuvant Therapy in Patients with High-Risk HER2-positive Urothelial Cancers [Protocol 11-163]	Bajorin, Dean, MD
A Phase II Study of Tesetaxel in Patients with Previously Treated Metastatic Transitional Cell Urothelial Cancer [Protocol 10-135]	Bajorin, Dean, MD
A Phase II Study of TKI258 in Patients with Advanced Urothelial Carcinoma [Protocol 10-058]	Bajorin, Dean, MD
A Phase III Study of Mitomycin C versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer [Protocol 09-118]	Dalbagni, Guido, MD
A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration [Protocol 05-001]	Chi, Dennis, MD
A Prospective Study of Quality of Life in Patients with Invasive Bladder Cancer [Protocol 08-076]	Bochner, Bernard, MD
A Prospective, Randomized Trial Comparing Robotic and Open Radical Cystectomy [Protocol 10-016]	Laudone, Vincent, MD

Title